%D9%81%D9%84%D9%88%D8%AA%D9%8A%D9%83%D8%A7%D8%B2%D9%88%D9%86%D9%81%D9%84%D9%88%D8%AA%DB%8C%DA%A9%D8%A7%D8%B2%D9%88%D9%86Category:FluticasoneFluticasonFluticasoneFluticasonaFlutikasona%D9%81%D9%84%D9%88%D8%AA%DB%8C%DA%A9%D8%A7%D8%B2%D9%88%D9%86FluticasoneFlutikazonFluticasone%E3%83%95%E3%83%AB%E3%83%81%E3%82%AB%E3%82%BE%E3%83%B3%ED%94%8C%EB%A3%A8%ED%8B%B0%EC%B9%B4%EC%86%90Flutykazon%D0%A4%D0%BB%D1%83%D1%82%D0%B8%D0%BA%D0%B0%D0%B7%D0%BE%D0%BDFlutikazonFlutikazonQ1002165%E6%B0%9F%E6%9B%BF%E5%8D%A1%E6%9D%BE
about
Anti-IgE Monoclonal Antibody Treatment in Patients With Allergic Asthma.DYmista NAsal Spray in CHInese PatientsStudy to Compare QVM149 and Free Triple Combination of Salmeterol/Fluticasone + TiotropiumSymbicort Onset of Action 1Atlantis SymbicortSymbicort Onset of Action 2Rhinocort Aqua Versus Placebo and Fluticasone PropionateClinical Trial of the Efficacy and Safety of Beclomethasone Dipropionate Plus Formoterol vs Fluticasone Propionate Plus Salmeterol in the 6 Months Step Down Treatment of AsthmaA Study to Evaluate MK0476 and Fluticasone to Control Asthma in Patients With Mild Persistent Asthma (0476-910)Differential Adrenoreceptor Mediated Tachyphylaxis and UpregulationNo Resistance After Long Term Treatment SERETIDESERETIDE Vs FLIXOTIDE In Mild Persistent Asthma (GINAII)A Study To Investigate The Effect Of Inhaled Fluticasone Propionate On The Bronchial Responsiveness To Leukotriene D4 In Asthmatics PatientsA 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg BID To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg BID In Symptomatic Subjects With AsthmaA 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg Twice Daily To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg Twice Daily In Symptomatic Patients With AsthmaA Study of Flovent in Patients With Eosinophilic EsophagitisStudy of Inhaled Glucocorticosteroids/Long-Acting Bronchodilator Drugs in Subjects With Asthma That Have Been Taking Inhaled Glucocorticosteroids (Study P04705AM1)Clinical Assessment Of GW815SF Salmeterol/Fluticasone Propionate(HFA MDI) In Pediatric Patients With Bronchial Asthma -A Long Term (24-week) Study-Clinical Assessment Of GW815SF HFA MDI In Pediatric Patients With Bronchial AsthmaStudy Of Airway Physiology In Adults. SERETIDE DISKUS® Inhaler and FLIXOTIDE® Inhaler Are Trademarks of GSK Croup of Companies.FLOVENT Hydrofluoroalkane (HFA) In 6-12 Month Old SubjectsSpacer Comparison In Adult AsthmaticsRepeat Dose Study of Fluticasone Propionate/Salmeterol Versus Fluticasone Propionate + Salmeterol In AsthmaticsResults Of Patient Rated Asthma Control Test In Comparison To Diary Card DataSERETIDE 50/500mcg Versus Tiotropium Bromide On Exacerbation Rates In Severe Chronic Obstructive Pulmonary DiseaseBI 671800 ED in Steroid-naive Asthmatic PatientsFlixonase Safety in Patients With Allergic Rhinitis (AR)An Allergen BioCube (ABC) Study Evaluating the Onset of Action of Fluticasone Furoate Nasal Spray and Olopatadine Nasal Spray Compared to PlaceboA Study To Explore The Effect On Inflammatory Markers After Nasal Allergen Challenge In Subjects With Seasonal Allergic Rhinitis And The Effect Of A Single Dose Of Ibuprofen Or Fluticasone Propionate On The Allergen Response.Comparison of Flutiform, Fluticasone and Seretide in Treatment of Moderate to Severe Asthma in Paediatric Patients6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years OldInhaled Fluticasone Furoate/Vilanterol Safety and Tolerability, PK and PD StudyAn Investigation of the Pharmacokinetics of GSK961081 and Fluticasone Propionate in Healthy VolunteersCharacterization of Lung Function Profile of Inhaled Tiotropium + Olodaterol Fixed Dose Combination Compared to Fluticasone Propionate + Salmeterol Fixed Dose Combination in COPD PatientsBest African American Response to Asthma DrugsSensitivity of Pharmacokinetics to Differences in Aerodynamic Particle Size DistributionEffects of Multiple Nasal Exposures to House Dust Mite Allergen on Nasal and Body Inflammation and Airway SensitivityShould Non-eosinophilic Asthmatic Subjects be Treated With Inhaled Corticosteroids?Open-label, Safety and Efficacy Study of Pulmicort® Turbuhaler® in Japanese Children With Bronchial AsthmaStudy Of RV-39 In Patients Who Also Have Asthma
P4844
Fluticasone uptake across Calu-3 cells is mediated by salmeterol when deposited as a combination powder inhaler.Pharmacogenetics of asthma controller treatment.Itraconazole and inhaled fluticasone causing hypothalamic-pituitary-adrenal axis suppression in adults with cystic fibrosis.Asthma outcomes and costs of therapy with extrafine beclomethasone and fluticasone.NAVIGATE II: Randomized, double-blind trial of the exhalation delivery system with fluticasone for nasal polyposisThe complex pathophysiology of allergic rhinitis: scientific rationale for the development of an alternative treatment optionUse of PBPK Modeling To Evaluate the Performance of Dissolv It, a Biorelevant Dissolution Assay for Orally Inhaled Drug ProductsFluticasone-Vilanterol as Needed for the Treatment of Mild Asthma in AdultsEfficacy and Safety APT-1011 in Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2)
P921
Q114085-142E08B5-2E7D-4143-9DE5-AC436380F1A3Q183344-7A15D8F9-92A7-4DA9-A911-96E5409317BCQ18553870-2462173C-38FA-453A-BD74-3191B0BDC7A9Q18554536-9A7136D2-B171-4EF7-9065-7E93080B4C0AQ2057356-3074EFE2-84D1-4986-922E-E66CE8DB956DQ3286546-6EBB3378-7927-4194-945C-7103E2180172Q3740609-94B196FC-2653-45F5-A709-BB4D40B92301
P2176
Q47521190-1C6ECEAF-CA8F-484C-8D07-32D2799587C5Q47521191-64AD39FF-886A-4E69-8BE4-8714E2DD9695Q47521424-BB2AC96C-EEBB-490F-8DF1-D83C25B47250Q47521620-756B6844-4674-48E2-8A8A-845EEDF19F76Q47521624-5D457BE9-059B-4DDE-AEE7-A972EF8BC78FQ47522283-BB7AF654-39F7-4D38-B85B-EA55B570B8B7Q47522323-0A08A6AD-3811-48B6-B134-F1C4FD7C6A49Q48826120-CC7120D8-39E0-41B8-B862-89DDBF2FEC28Q48826231-3A4E8025-3C21-4B69-A405-DEC847C0E44CQ48826277-A938CE46-B377-44C2-85A2-8836ADD3BCC8Q48829182-99641CAF-08C0-4CA9-9FD9-665DAE2C2172Q48829186-339E523C-D3D3-4991-8A76-DD82A90055C1Q48829253-8668307E-4D89-43EC-89D7-06A30E6AEF65
P3781
description
Arzneistoff
@de
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Fluticason
@de
Flutikasona
@eu
fluticason
@cs
fluticasona
@es
fluticasona
@pt-br
fluticasone
@en
fluticasone
@fr
fluticasone
@it
fluticasone
@nl
flutikason
@nn
type
label
Fluticason
@de
Flutikasona
@eu
fluticason
@cs
fluticasona
@es
fluticasona
@pt-br
fluticasone
@en
fluticasone
@fr
fluticasone
@it
fluticasone
@nl
flutikason
@nn
altLabel
90566-53-3
@fr
90566-53-3
@nn
90566-53-3
@pt-br
Advair®
@en
C22H27F3O4S
@fr
C22H27F3O4S1
@it
Flovent HFA®
@en
Veramyst®
@en
fluticazon
@cs
Фликсоназе
@ru
prefLabel
Fluticason
@de
Flutikasona
@eu
fluticason
@cs
fluticasona
@es
fluticasona
@pt-br
fluticasone
@en
fluticasone
@fr
fluticasone
@it
fluticasone
@nl
flutikason
@nn